Search alternatives:
"xlink implementing" » "xlink implemented" (Expand Search)
"program implementinged" » "program implementeded" (Expand Search), "program implemented" (Expand Search), "program implementingrules" (Expand Search)
"program implementingedinged" » "program implementededinged" (Expand Search), "program implementedinged" (Expand Search), "program implementingrulesinged" (Expand Search)
Showing 81 - 100 results of 206 for search '(("xlink implementing") OR ((("program implementinged") OR ("program implementingedinged"))))', query time: 0.37s Refine Results
  1. 81
    Effect of various treatment regimens on cancer cell viability.

    Effect of various treatment regimens on cancer cell viability. by Mohammad R. Nikmaneshi (16185668)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 82
    Themes, sub-themes and theoretical domains framework domains.

    Themes, sub-themes and theoretical domains framework domains. by Joshua Brown (669431)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 83
    Phenotype characterization, distribution, and survival.

    Phenotype characterization, distribution, and survival. by Annika Weidenhammer (21433547)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Fig 9 -

    Fig 9 - by Mohammad R. Nikmaneshi (16185668)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 85
    Mtb binds to Lipobiotin-functionalized magnetic beads (LMBs).

    Mtb binds to Lipobiotin-functionalized magnetic beads (LMBs). by Julia Hansen (3907219)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 86
    Data depicted in Fig 1.

    Data depicted in Fig 1. by Julia Hansen (3907219)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 87
    Contextual considerations for GVRO implementation by CFIR domain and construct.

    Contextual considerations for GVRO implementation by CFIR domain and construct. by Veronica A. Pear (10325814)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 88
    Key informant characteristics.

    Key informant characteristics. by Veronica A. Pear (10325814)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 89
    Data depicted in Fig 5.

    Data depicted in Fig 5. by Julia Hansen (3907219)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 90
    Trajectories of GDMT up-titration limiting factors over a period of 1 year during up-titration.

    Trajectories of GDMT up-titration limiting factors over a period of 1 year during up-titration. by Annika Weidenhammer (21433547)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    The effect of LMB assay on qPCR-based detection of Mtb in saliva from TB patients and healthy subjects (cohort #1).

    The effect of LMB assay on qPCR-based detection of Mtb in saliva from TB patients and healthy subjects (cohort #1). by Julia Hansen (3907219)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 92
    Spatial maps of interstitial fluid pressure (IFP, top panels) and anti-cancer drug distribution in the tumor and surrounding tissue (bottom panels).

    Spatial maps of interstitial fluid pressure (IFP, top panels) and anti-cancer drug distribution in the tumor and surrounding tissue (bottom panels). by Mohammad R. Nikmaneshi (16185668)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 93
    Baseline characteristics of HFrEF patients grouped according to the presence or absence of factors limiting GDMT up-titration.

    Baseline characteristics of HFrEF patients grouped according to the presence or absence of factors limiting GDMT up-titration. by Annika Weidenhammer (21433547)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    Data depicted in Fig 4.

    Data depicted in Fig 4. by Julia Hansen (3907219)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 95
    Use and dosage of HF therapy at baseline, 6 months, and 1 year depending on GDMT up-titration limiting factors.

    Use and dosage of HF therapy at baseline, 6 months, and 1 year depending on GDMT up-titration limiting factors. by Annika Weidenhammer (21433547)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 96
    Schematic illustration of the Lipobiotin magnetic bead assay (LMB assay).

    Schematic illustration of the Lipobiotin magnetic bead assay (LMB assay). by Julia Hansen (3907219)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 97
    Dose schedules of anti-cancer and anti-angiogenesis drugs.

    Dose schedules of anti-cancer and anti-angiogenesis drugs. by Mohammad R. Nikmaneshi (16185668)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 98
    Characteristics of clinicians participating in interviews on the fan for breathlessness management (N = 12).

    Characteristics of clinicians participating in interviews on the fan for breathlessness management (N = 12). by Joshua Brown (669431)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 99
    Distribution and outcome of GDMT up-titration limiting factors.

    Distribution and outcome of GDMT up-titration limiting factors. by Annika Weidenhammer (21433547)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 100
    Factors limiting GDMT up-titration of HF drugs in HFrEF.

    Factors limiting GDMT up-titration of HF drugs in HFrEF. by Annika Weidenhammer (21433547)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: